Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 3
1982 2
1983 4
1984 2
1987 2
1988 3
1989 4
1990 3
1992 3
1993 4
1994 1
1995 3
1996 4
1997 3
1998 2
1999 2
2000 5
2001 2
2002 1
2005 4
2006 3
2007 4
2011 3
2012 3
2013 1
2014 3
2015 6
2016 2
2017 2
2018 6
2019 6
2020 1
2021 4
2022 5
2023 8
2024 19
2025 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy.
Fujiwara Y, Kato S, Nesline MK, Conroy JM, DePietro P, Pabla S, Kurzrock R. Fujiwara Y, et al. Among authors: conroy jm. Cancer Treat Rev. 2022 Nov;110:102461. doi: 10.1016/j.ctrv.2022.102461. Epub 2022 Aug 30. Cancer Treat Rev. 2022. PMID: 36058143 Free PMC article. Review.
Immunologic Factors Associated with Differential Response to Neoadjuvant Chemoimmunotherapy in Triple-Negative Breast Cancer.
Seager RJ, Ko H, Pabla S, Senosain MF, Kalinski P, Van Roey E, Gao S, Strickland KC, Previs RA, Nesline MK, Hastings S, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Seager RJ, et al. Among authors: conroy jm. J Pers Med. 2024 Apr 30;14(5):481. doi: 10.3390/jpm14050481. J Pers Med. 2024. PMID: 38793063 Free PMC article.
OX40/OX40 ligand and its role in precision immune oncology.
Thapa B, Kato S, Nishizaki D, Miyashita H, Lee S, Nesline MK, Previs RA, Conroy JM, DePietro P, Pabla S, Kurzrock R. Thapa B, et al. Among authors: conroy jm. Cancer Metastasis Rev. 2024 Sep;43(3):1001-1013. doi: 10.1007/s10555-024-10184-9. Epub 2024 Mar 25. Cancer Metastasis Rev. 2024. PMID: 38526805 Free PMC article. Review.
Viewing the immune checkpoint VISTA: landscape and outcomes across cancers.
Nishizaki D, Kurzrock R, Miyashita H, Adashek JJ, Lee S, Nikanjam M, Eskander RN, Patel H, Botta GP, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S. Nishizaki D, et al. Among authors: conroy jm. ESMO Open. 2024 Apr;9(4):102942. doi: 10.1016/j.esmoop.2024.102942. Epub 2024 Mar 18. ESMO Open. 2024. PMID: 38503143 Free PMC article.
TIM-3 transcriptomic landscape with clinical and immunomic correlates in cancer.
Ahmed J, Nishizaki D, Miyashita H, Lee S, Nesline MK, Pabla S, Conroy JM, DePietro P, Sicklick JK, Kato S, Kurzrock R. Ahmed J, et al. Among authors: conroy jm. Am J Cancer Res. 2024 May 15;14(5):2493-2506. doi: 10.62347/MQFF6404. eCollection 2024. Am J Cancer Res. 2024. PMID: 38859842 Free PMC article.
136 results